miR-218 regulates diabetic nephropathy via _targeting IKK-β and modulating NK-κB-mediated inflammation
- PMID: 31549412
- DOI: 10.1002/jcp.29224
miR-218 regulates diabetic nephropathy via _targeting IKK-β and modulating NK-κB-mediated inflammation
Abstract
Diabetic nephropathy (DN) is a common clinically relevant complication of diabetes that is associated with damage to the capillaries, yet the etiology of this condition remains unclear. Nuclear factor-kappa B (NF-κB) activation is known to be associated with DN-related inflammation and disease progression. Recent work indicated that microRNAs are diagnostic biomarkers of DN progression associated with inflammation in the progression of DN. miR-218 is known to play key regulatory roles in certain cancers in humans, while its influence on DN pathology remains uncertain. The present study, therefore, sought to assess how miR-218 influences the progression of disease in both a rat streptozotocin-induced model of DN and as well as an in vitro model system in which mouse podocytes were stimulated with high glucose levels. We found miR-218 to be markedly downregulated in both model systems relative to appropriate controls, and this downregulation was associated with IKK-β upregulation. In DN rat model, overexpressing miR-218 was sufficient to reduce renal injury. We further determined that podocyte proliferation was markedly impaired by glucose treatment, leading to the apoptotic death of these cells, and miR-218 mimics were able to reduce these phenotypes. Overexpressing miR-218 also significantly dampened inflammatory responses in this model system, as evidenced by reduced tumor necrosis factor-α, interleukin-6 (IL-6), IL-1β, and MCP-1 levels. We then confirmed that miR-218 _targeting the messenger RNA encoding IKK-β using a dual-luciferase reporter assay. Together, our results provide clear evidence that miR-218 regulate NF-κB-mediated inflammation, which is central to DN progression.
Keywords: IKK-β; NF-κB; diabetic nephropathy; inflammatory; miR-218.
© 2019 Wiley Periodicals, Inc.
Similar articles
-
MiR-874 alleviates renal injury and inflammatory response in diabetic nephropathy through _targeting toll-like receptor-4.J Cell Physiol. 2018 Jan;234(1):871-879. doi: 10.1002/jcp.26908. Epub 2018 Sep 1. J Cell Physiol. 2018. PMID: 30171701
-
MicroRNA-27a promotes podocyte injury via PPARγ-mediated β-catenin activation in diabetic nephropathy.Cell Death Dis. 2017 Mar 9;8(3):e2658. doi: 10.1038/cddis.2017.74. Cell Death Dis. 2017. PMID: 28277542 Free PMC article.
-
miR-451 suppresses the NF-kappaB-mediated proinflammatory molecules expression through inhibiting LMP7 in diabetic nephropathy.Mol Cell Endocrinol. 2016 Sep 15;433:75-86. doi: 10.1016/j.mce.2016.06.004. Epub 2016 Jun 3. Mol Cell Endocrinol. 2016. PMID: 27264074
-
The role of ubiquitination and sumoylation in diabetic nephropathy.Biomed Res Int. 2014;2014:160692. doi: 10.1155/2014/160692. Epub 2014 Jun 4. Biomed Res Int. 2014. PMID: 24991536 Free PMC article. Review.
-
MicroRNA-21: A Critical Pathogenic Factor of Diabetic Nephropathy.Front Endocrinol (Lausanne). 2022 Jul 5;13:895010. doi: 10.3389/fendo.2022.895010. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 35865316 Free PMC article. Review.
Cited by
-
Noncoding RNAs in Diabetic Nephropathy: Pathogenesis, Biomarkers, and Therapy.J Diabetes Res. 2020 Jun 19;2020:3960857. doi: 10.1155/2020/3960857. eCollection 2020. J Diabetes Res. 2020. PMID: 32656264 Free PMC article. Review.
-
TNF Signaling Acts Downstream of MiR-322/-503 in Regulating DM1 Myogenesis.Front Endocrinol (Lausanne). 2022 Apr 7;13:843202. doi: 10.3389/fendo.2022.843202. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 35464065 Free PMC article.
-
Applications and developments of gene therapy drug delivery systems for genetic diseases.Asian J Pharm Sci. 2021 Nov;16(6):687-703. doi: 10.1016/j.ajps.2021.05.003. Epub 2021 Jun 27. Asian J Pharm Sci. 2021. PMID: 35027949 Free PMC article. Review.
-
Effects of Intrahypothalamic Administration of microRNA Inhibitors and Mimetics on Blood Plasma Biomarkers in the Rat Aging.Dokl Biochem Biophys. 2024 Sep 16. doi: 10.1134/S1607672924701138. Online ahead of print. Dokl Biochem Biophys. 2024. PMID: 39283557
-
Prognostic Value of Serum Interleukin-6, NF-κB plus MCP-1 Assay in Patients with Diabetic Nephropathy.Dis Markers. 2022 Jun 17;2022:4428484. doi: 10.1155/2022/4428484. eCollection 2022. Dis Markers. 2022. PMID: 35756496 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases
Miscellaneous